New York Post on MSN13d
New treatment for hair loss shows promise — paid volunteers needed to test it out
I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...
GlobalData on MSN12h
Vyne doses first participant in Phase Ib plaque psoriasis treatment trial
Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for ...
Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly
Patients affected by sinus thrombosis are treated with blood thinners. Traditionally, these patients are prescribed vitamin K ...
Rolling Out5d
A revolutionary shift in schizophrenia treatment
Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.
Medical News Today10d
Rosuvastatin oral tablet interactions: Alcohol, medications, and other factors
Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...
New Atlas6d
Adding milk improves the effectiveness of oral drugs
Good old reliable milk. New research found that when it's combined with particular oral drugs, milk significantly improves ...
cidrap.umn7h
Shorter, all-oral drug-resistant TB regimens perform well in real-world setting, study finds
In a study in Belarus and Kazakhstan, 96.3% of patients with drug-resistant TB who received the regimens had successful treatment outcomes.
The American Journal of Managed Care7d
Oral Roflumilast Shows Promise for Moderate to Severe Psoriasis
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.